Core Insights - Analysts project Encompass Health (EHC) will report quarterly earnings of 1.38 billion, marking a 10.4% increase from the same quarter last year [1] - The consensus EPS estimate has been revised down by 0.3% in the past 30 days, indicating a reassessment by covering analysts [2] Earnings Estimates and Revisions - Revisions to earnings estimates are crucial indicators for predicting investor actions regarding the stock [3] - There is a strong correlation between earnings estimate revisions and short-term stock price performance [3] Key Metrics Projections - Analysts estimate 'Revenues- Inpatient Rehabilitation' will be 37.68 million, indicating a year-over-year change of 25.6% [5] - 'Net patient revenue per discharge' is expected to be 20,538 in the previous year [5] - Total discharges are projected to reach 63,313, compared to 59,247 in the same quarter last year [6] Stock Performance - Encompass Health shares have increased by 10.5% in the past month, outperforming the Zacks S&P 500 composite's 1.7% increase [6] - Despite the recent performance, EHC holds a Zacks Rank 4 (Sell), suggesting expected underperformance relative to the overall market in the near term [6]
Stay Ahead of the Game With Encompass Health (EHC) Q4 Earnings: Wall Street's Insights on Key Metrics